Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

BioGaia AB - Year-end report 2017

PR Newswire February 8, 2018

Response Genetics, Inc. Announces Presentations at the American Society of Clinical Oncology's Gastrointestinal Cancers Symposium 2015

GlobeNewswire January 15, 2015

IBM Watson Group Awards University of Texas at Austin Top Spot in Intercollegiate Competition

PR Newswire January 15, 2015

Avagenesis Corp. to Acquire Curastem Biomedical Corp.

Filing Services Canada January 15, 2015

Tumor suppressor protein plays key role in maintaining immune balance

PR Newswire January 15, 2015

ERYTECH Announces Its Financial Calendar for 2015

Business Wire January 15, 2015

Caris Life Sciences' Multiplatform Tumor Profiling of Hepatocellular and Biliary Tract Carcinomas Yields Insights into Novel and Conventional Therapeutic Options

PR Newswire January 15, 2015

Dr. Henry R. Kranzler earns the Hazelden Betty Ford Foundation's Dan Anderson Research Award

PR Newswire January 15, 2015

Research and Markets: Overview of the Human Microbiome: Biomedical Implications and Birth of a Market

Business Wire January 15, 2015

Medisico Plc - Appointment of Directors

PR Newswire January 15, 2015

Society for Brain Mapping and Therapeutics holds its 12th Annual World Congress at the LA Convention Center in March announcing its African Brain Mapping Initiative

PR Newswire January 15, 2015

Viterra Partners with Agriculture in the Classroom to Raise Ag Awareness

Marketwired January 15, 2015

W2O Group Announces Appointment of Healthcare Communications Leader, Greg Matthews, to Mayo Clinic Center for Social Media Health Network's External Advisory Board

Business Wire January 15, 2015

Lupus Organizations Collaborate to Further Advance Lupus Research

PR Newswire January 15, 2015

Multiplatform Tumor Profiling from Caris Molecular Intelligence(TM) Identifies Therapeutic Options for Patients with TKI-resistant Gastrointestinal Stromal Tumors

PR Newswire January 15, 2015

CorMedix Inc. Receives Fast Track Designation for Neutrolin®

PR Newswire January 15, 2015

Research and Markets: Digital Pathology Insights: Imaging Technologies, Expert Perspectives, Standardization, and Current Outlooks

Business Wire January 15, 2015

Arsenal Medical Announces Results of Novel Translational Research Study Determining Human Dose for its Trauma Foam Technology

Business Wire January 15, 2015

Five Years Since the Deepwater Horizon Oil Spill: What We Know Now

Business Wire January 15, 2015

Dedicated Computing Joins the Intel® Cluster Ready Program to Offer High-Performance Computing Cluster Solutions for Bioinformatics Research

PR Newswire January 15, 2015